TITLE

Virus found in patients with ALS

PUB. DATE
May 2000
SOURCE
CMAJ: Canadian Medical Association Journal;5/16/2000, Vol. 162 Issue 10, p1475
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Reports on a breakthrough study by French researchers that found solid evidence of a viral infection in patients with amyotrophic lateral sclerosis (ALS). History of medical knowledge about ALS; Discovery of RNA from an enterovirus in patients with ALS; How the discovery bolsters a theory that ALS has a viral cause.
ACCESSION #
3154462

 

Related Articles

  • Corticomotor organisation and motor function in multiple sclerosis. Thickbroom, Gary W.; Byrnes, Michelle L.; Archer, Sarah A.; Kermode, Allan G.; Mastaglia, Frank L. // Journal of Neurology;Jul2005, Vol. 252 Issue 7, p765 

    Our objective was to determine whether there are changes in the corticomotor map for the hand in multiple sclerosis, and whether these changes correlate with indices of motor function and measures of corticomotor conduction or excitability. Transcranial magnetic stimulation (TMS) maps, motor...

  • Basic facts and figures. Wood-Allum, Clare; Shaw, Pamela // GP: General Practitioner;3/18/2002, p57 

    Focuses on motor neurone disease (MND), one of the three most common neurodegenerative diseases in adulthood. Age groups affected by the disease; Symptoms of amyotrophic lateral sclerosis, a subtype of MND; Other subtypes of the disease.

  • Motor Neurone Disease Australia. BERRY, EMI // Money (Australia Edition);Mar2015, Issue 176, p26 

    The article offers information on the Motor Neurone Disease Australia, which aims to promote optimal care for people with motor neurone disease (MND) and finance MND research.

  • Improving survival in amyotrophic lateral sclerosis: future treatments in a modern service. Hrastelj, James; Robertson, Neil // Journal of Neurology;Jul2015, Vol. 262 Issue 7, p1791 

    An introduction to the journal is presented where the editor discusses various reports published in the issue which includes the discovery of another gene associated with amyotrophic lateral sclerosis (ALS), the association between methylation of the C9orf72 promoter and disease severity and the...

  • A zebrafish model exemplifies the long preclinical period of motor neuron disease. Ramesh, Tennore M.; Shaw, Pamela J.; McDearmid, Jonathan // Journal of Neurology, Neurosurgery & Psychiatry;Nov2014, Vol. 85 Issue 11, p1288 

    A letter to the editor is presented in response to the article "Amyotrophic lateral sclerosis: a long preclinical period?" by A. Eisen and colleagues published in a issue of 2014, is presented.

  • Response to a letter by Dr T Ramesh. Eisen, Andrew // Journal of Neurology, Neurosurgery & Psychiatry;Nov2014, Vol. 85 Issue 11, p1289 

    A response from the author of the article "Amyotrophic lateral sclerosis: a long preclinical period?" that was published in a issue of 2014 is presented.

  • Motor neurone disease. Shaw, Pamela J // BMJ: British Medical Journal (International Edition);04/24/99, Vol. 318 Issue 7191, p1118 

    Discusses the motor neurone disease, one of the most common neurodegenerative diseases of adult onset. Incidence of the disease; Pathogenesis of motor neurone disease; Treatment.

  • Erratum to: Caregiver burden in amyotrophic lateral sclerosis: a cross-sectional investigation of predictors. Burke, Tom; Elamin, Marwa; Galvin, Miriam; Gallagher, Laura; Hardiman, Orla; Pender, Niall // Journal of Neurology;Dec2015, Vol. 262 Issue 12, p2799 

    A correction to the article "Caregiver Burden in Amyotrophic Lateral Sclerosis: A Cross-Sectional Investigation of Predictors," in a 2015 issue of the "Journal of Neurology" is presented.

  • Interpreting change scores on the Amyotrophic Lateral Sclerosis Assessment Questionnaire (ALSAQ-40). Jenkinson, C; Peto, V; Jones, G; Fitzpatrick, R // Clinical Rehabilitation;Jul2003, Vol. 17 Issue 4, p380 

    Objectives: To determine the amount of change over time on the five dimensions of the 40-item Amyotrophic Lateral Sclerosis Assessment Questionnaire (ALSAQ-40) that are subjectively meaningful to patients. Minimally important differences (MID), effect sizes (ES) and standardized response means...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics